2019 / 04

Next Paper
DOI: 10.24075/brsmu.2019.049

ORIGINAL RESEARCH

The potential of exosomes for the diagnosis and treatment of Duchenne muscular dystrophy

Galkin II1,2, Egorova TV1,3
About authors

1 Marlin Biotech LLC, Moscow, Russia

2 Belozersky Institute of Physico-Chemical Biology, Moscow, Russia

3 Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia

Correspondence should be addressed: Tatiana V. Egorova
Vavilova 34/5, Moscow, 119334; moc.hcetoibnilram@aveirtimid.t

About paper

Author contribution: Galkin II, Egorova TV — literature analysis and manuscript preparation.

Received: 2019-07-21 Accepted: 2019-08-05 Published online: 2019-08-12
|
  1. Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018; 17 (3): 251–67. DOI: 10.1016/S1474-4422(18)30024-3. PubMed PMID: 29395989; PMCID: PMC5869704.
  2. Duan D. Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy. Mol Ther. 2018; 26 (10): 2337–56. DOI: 10.1016/j.ymthe.2018.07.011. PubMed PMID: 30093306; PMCID: PMC6171037.
  3. Lim KR, Maruyama R, Yokota T. Eteplirsen in the treatment of Duchenne muscular dystrophy. Drug Des Devel Ther. 2017; (11): 533–45. DOI: 10.2147/DDDT.S97635. PubMed PMID: 28280301; PMCID: PMC5338848.
  4. Bunggulawa EJ, Wang W, Yin T, Wang N, Durkan C, Wang Y, et al. Recent advancements in the use of exosomes as drug delivery systems. J Nanobiotechnology. 2018; 16 (1): 81. DOI: 10.1186/ s12951-018-0403-9. PubMed PMID: 30326899; PMCID: PMC6190562.
  5. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. The Journal of cell biology. 2013; 200 (4): 373–83. DOI: 10.1083/jcb.201211138. PubMed PMID: 23420871; PMCID: PMC3575529.
  6. Gao X, Ran N, Dong X, Zuo B, Yang R, Zhou Q, Moulton HM, Seow Y, Yin H. Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy. Sci Transl Med. 2018; 10 (444). DOI: 10.1126/scitranslmed.aat0195. PubMed PMID: 29875202.
  7. Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017; 546 (7659): 498–503. DOI: 10.1038/nature22341. PubMed PMID: 28607485; PMCID: PMC5538883.
  8. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011; 29 (4): 341–5. DOI: 10.1038/nbt.1807. PubMed PMID: 21423189.
  9. Kim YS, Ahn JS, Kim S, Kim HJ, Kim SH, Kang JS. The potential theragnostic (diagnostic + therapeutic) application of exosomes in diverse biomedical fields. Korean J Physiol Pharmacol. 2018; 22 (2): 113–25. DOI: 10.4196/kjpp.2018.22.2.113. PubMed PMID: 29520164; PMCID: PMC5840070.
  10. Coenen-Stass AML, Wood MJA, Roberts TC. Biomarker Potential of Extracellular miRNAs in Duchenne Muscular Dystrophy. Trends Mol Med. 2017; 23 (11): 989–1001. DOI: 10.1016/j. molmed.2017.09.002. PubMed PMID: 28988850.
  11. Aminzadeh MA, Rogers RG, Fournier M, Tobin RE, Guan X, Childers MK, et al. Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy. Stem Cell Reports. 2018; 10 (3): 942–55. DOI: 10.1016/j. stemcr.2018.01.023. PubMed PMID: 29478899; PMCID: PMC5918344.
  12. Rogers RG, Fournier M, Sanchez L, Ibrahim AG, Aminzadeh MA, Lewis MI, et al. Disease-modifying bioactivity of intravenous cardiosphere-derived cells and exosomes in mdx mice. JCI Insight. 2019; 4 (7). DOI: 10.1172/jci.insight.125754. PubMed PMID: 30944252; PMCID: PMC6483717.
  13. Su X, Shen Y, Jin Y, Jiang M, Weintraub N, Tang Y. Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice. J Vis Exp. 2019; (146). DOI: 10.3791/59320. PubMed PMID: 31033952.
  14. Su X, Jin Y, Shen Y, Ju C, Cai J, Liu Y, et al. Exosome-Derived Dystrophin from Allograft Myogenic Progenitors Improves Cardiac Function in Duchenne Muscular Dystrophic Mice. J Cardiovasc Transl Res. 2018; 11 (5): 412–9. DOI: 10.1007/s12265-018- 9826-9. PubMed PMID: 30155598; PMCID: PMC6212302.
  15. Bier A, Berenstein P, Kronfeld N, Morgoulis D, Ziv-Av A, Goldstein H, et al. Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy. Biomaterials. 2018; (174): 67–78. DOI: 10.1016/j. biomaterials.2018.04.055. PubMed PMID: 29783118.